Shantha launches vaccine production facility
Shantha Biotechnics donated 100,000 (1 lakh) hepatitis-B vaccine doses to the Andhra Pradesh government to commemorate the inauguration of its new state-of-the-art GMP compliant vaccine manufacturing facility on the outskirts of Hyderabad.

Biocon begins phase II trials of cancer drug
Biocon Limited has started phase II clinical trials of its drug TheraCIM (h-R3), a humanised monoclonal antibody, for the treatment of head and neck cancers, informed a press release.

Ranbaxy receives USFDA approval to market clorazepate dipotassium tabs
RANBAXY Laboratories Limited announced through a press release that the company has received approval from the US Food and Drug Administration to manufacture and market clorazepate dipotassium tablets USP, 3.75 mg, 7.5 mg, and 15 mg.